Oncothyreon Canada Inc. (formerly Biomira Inc.)
Profile
Mailing Address: Investor Relations - Attn. Ed Taylor
Edmonton Research Park
2011 - 94 Street
Edmonton, Alberta
T6N 1H1
Head Office Address: Investor Relations - Attn. Ed Taylor
Edmonton Research Park
2011 - 94 Street
Edmonton, Alberta
T6N 1H1
Contact Name: Ed Taylor Principal Regulator: Alberta
Business e-mail address: IR@biomira.com Short Form Prospectus Issuer: Yes
Telephone Number: 780 490-2818 Reporting Jurisdictions: Ceased Reporting
Fax Number: 780 450-4772 Stock Exchange: N/A
Date of Formation: Aug 23 1985 Stock Symbol:
Jurisdiction Where Formed: Canada / Federal Auditor: Deloitte & Touche LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 09161R Transfer Agent: Computershare Trust Company of Canada
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


This company is a previous issuer to   Cascadian Therapeutics, Inc.
View This Company's Documents